{
  "experiment_info": {
    "experiment_name": "paper_12_Hyaluronan_A",
    "run_number": 10,
    "total_runs": 10,
    "timestamp": "20250624_020624",
    "run_start_time": "2025-06-24T03:17:01.926375",
    "run_end_time": "2025-06-24T03:17:38.646022"
  },
  "inputs": {
    "initial_description": {
      "timestamp": "2025-06-24T03:17:01.927476",
      "data": {
        "description": "During embryonic development, cardiac valves arise at specific regions in the cardiac endothelium that swell up due to enhanced extracellular matrix production (so-called endocardial cushions). An important extracellular matrix component that is produced by the endocardial cells is the glycosaminoglycan hyaluronan. A deficiency in hyaluronan synthesis results in a failure to form endocardial cushions and a loss of their cellularization by a process called endothelial-to-mesenchymal transformation. Expression of the major hyaluronan synthase Has2 is under the influence of both positive and negative regulators. MicroRNA-dependent degradation of Has2 is required to control extracellular hyaluronan levels and thereby the size of the endocardial cushions. In this article, we review the current literature on hyaluronan synthesis during cardiac valve formation and propose that a balanced activity of both positive and negative regulators is required to maintain the critical homeostasis of hyaluronan levels in the extracellular matrix and thereby the size of the endocardial cushions. The activating and inhibitory interactions between microRNA-23, Has2, and hyaluronan are reminiscent of a reaction\u2013diffusion system. Using a mathematical modeling approach we show that the system can produce a confined expression of hyaluronan, but only if the inhibitory signal is transferred to adjacent cells in exosomes."
      }
    }
  },
  "llm_responses": [
    {
      "step": "llm_response",
      "timestamp": "2025-06-24T03:17:16.535105",
      "prompt": "Original description: During embryonic development, cardiac valves arise at specific regions in the cardiac endothelium that swell up due to enhanced extracellular matrix production (so-called endocardial cushions). An important extracellular matrix component that is produced by the endocardial cells is the glycosaminoglycan hyaluronan. A deficiency in hyaluronan synthesis results in a failure to form endocardial cushions and a loss of their cellularization by a process called endothelial-to-mesenchymal transformation. Expression of the major hyaluronan synthase Has2 is under the influence of both positive and negative regulators. MicroRNA-dependent degradation of Has2 is required to control extracellular hyaluronan levels and thereby the size of the endocardial cushions. In this article, we review the current literature on hyaluronan synthesis during cardiac valve formation and propose that a balanced activity of both positive and negative regulators is required to maintain the critical homeostasis of hyaluronan levels in the extracellular matrix and thereby the size of the endocardial cushions. The activating and inhibitory interactions between microRNA-23, Has2, and hyaluronan are reminiscent of a reaction\u2013diffusion system. Using a mathematical modeling approach we show that the system can produce a confined expression of hyaluronan, but only if the inhibitory signal is transferred to adjacent cells in exosomes.\n\nClarifications provided: \n\n\n    Return ONLY a JSON object with ontology annotations. Format all IDs and terms exactly as specified in the system message.",
      "system_message": "You are a biological modeling expert. Create structured ontology annotations based on the provided information. \n    Include relevant Cell Ontology, GO, and MeSH terms where applicable.\n    Return ONLY a JSON object with categories for different ontology types.\n    \n    Format requirements:\n    1. Category names must be exact:\n       - \"CellOntology\" (not \"Cell Ontology\" or \"Cell  Ontology\")\n       - \"GeneOntology\" (not \"Gene Ontology\" or \"Gene  Ontology\")\n       - \"MeSH\" (not \"MeSH Terms\" or \"MeSH  Terms\")\n    \n    2. Ontology IDs must be exact without spaces:\n       - Cell Ontology: \"CL:0000000\" (not \"CL : 000 000 0\")\n       - Gene Ontology: \"GO:0000000\" (not \"GO : 000 000 0\")\n       - MeSH: \"D000000\" (not \"D 000 000\")\n    \n    3. Term names must be exact without extra spaces:\n       - \"Epithelial\" (not \"Ep ith elial\")\n       - \"Mesenchymal\" (not \"Mes ench ym al\")\n    \n    Example format:\n    {\n        \"CellOntology\": [\n            {\n                \"id\": \"CL:0000000\",\n                \"term\": \"Epithelial\"\n            }\n        ],\n        \"GeneOntology\": [\n            {\n                \"id\": \"GO:0000000\",\n                \"term\": \"Cell Division\"\n            }\n        ],\n        \"MeSH\": [\n            {\n                \"id\": \"D000000\",\n                \"term\": \"Cell Proliferation\"\n            }\n        ]\n    }\n    \n    Do not include any explanations or thinking process.",
      "response": "<think>\nAlright, let's tackle this query. The user wants structured ontology annotations based on the provided biological information. They specified CellOntology, GeneOntology, and MeSH terms. I need to make sure the categories are exact, the IDs have no spaces, and the terms are correctly spelled.\n\nFirst, looking at the original description: it mentions cardiac endothelium, endocardial cushions, endothelial-to-mesenchymal transformation, hyaluronan synthesis, Has2, microRNA-23, exosomes, and mathematical modeling. \n\nFor CellOntology, terms like \"cardiac endothelial cells\" and \"mesenchymal cell\" come to mind. Checking Cell Ontology, \"endocardial cell\" is CL:0002250, and \"mesenchymal cell\" is CL:0000669. So those should be included.\n\nGeneOntology entries would relate to the processes described. Endothelial to mesenchymal transition is GO:0060973. Hyaluronan biosynthetic process is GO:0030212. Glycosaminoglycan metabolic process is GO:0030203. Extracellular matrix organization is GO:0070613. Negative regulation of extracellular matrix organization might be GO:0090076. \n\nMeSH terms: Hyaluronic Acid is D006820. Extracellular Matrix is D005109. Endothelial Cells is D004727. Exosomes is D055354. MicroRNAs is D036342. Mathematical Modeling here would be under Models, Theoretical as D008957. \n\nNeed to verify each ID and term spelling. Make sure there's no extra spaces in terms like \"Endothelial to mesenchymal cell transformation\" vs the correct \"endothelial to mesenchymal transition\". Also check MeSH IDs: Hyaluronic Acid is D006820, yes. Exosomes D055354. \n\nPutting it all together, structure the JSON with exact category names and proper formatting. Ensure all IDs are correctly formatted without spaces. Avoid any terms not directly mentioned, like \"cardiac valves\" if there's no exact ontology term. Double-check each entry against the ontologies to confirm IDs and terms.\n</think>\n\n{\n    \"CellOntology\": [\n        {\n            \"id\": \"CL:0002250\",\n            \"term\": \"endocardial cell\"\n        },\n        {\n            \"id\": \"CL:0000669\",\n            \"term\": \"mesenchymal cell\"\n        }\n    ],\n    \"GeneOntology\": [\n        {\n            \"id\": \"GO:0060973\",\n            \"term\": \"endothelial to mesenchymal transition\"\n        },\n        {\n            \"id\": \"GO:0030212\",\n            \"term\": \"hyaluronan biosynthetic process\"\n        },\n        {\n            \"id\": \"GO:0030203\",\n            \"term\": \"glycosaminoglycan metabolic process\"\n        },\n        {\n            \"id\": \"GO:0070613\",\n            \"term\": \"extracellular matrix organization\"\n        },\n        {\n            \"id\": \"GO:0090076\",\n            \"term\": \"negative regulation of extracellular matrix organization\"\n        }\n    ],\n    \"MeSH\": [\n        {\n            \"id\": \"D006820\",\n            \"term\": \"Hyaluronic Acid\"\n        },\n        {\n            \"id\": \"D005109\",\n            \"term\": \"Extracellular Matrix\"\n        },\n        {\n            \"id\": \"D004727\",\n            \"term\": \"Endothelial Cells\"\n        },\n        {\n            \"id\": \"D055354\",\n            \"term\": \"Exosomes\"\n        },\n        {\n            \"id\": \"D036342\",\n            \"term\": \"MicroRNAs\"\n        },\n        {\n            \"id\": \"D008957\",\n            \"term\": \"Models, Theoretical\"\n        }\n    ]\n}"
    },
    {
      "step": "llm_response",
      "timestamp": "2025-06-24T03:17:38.587591",
      "prompt": "Generate a valid CompuCell3D simulation file based on these ontology annotations.\n    Return ONLY the Python code:\n\n{'CellOntology': {'endocardial cell (CL:0002250)', 'mesenchymal cell (CL:0000669)'}, 'GeneOntology': {'glycosaminoglycan metabolic process (GO:0030203)', 'endothelial to mesenchymal transition (GO:0060973)', 'extracellular matrix organization (GO:0070613)', 'hyaluronan biosynthetic process (GO:0030212)', 'negative regulation of extracellular matrix organization (GO:0090076)'}, 'MeSH': {'Models, Theoretical (D008957)', 'Endothelial Cells (D004727)', 'Hyaluronic Acid (D006820)', 'Exosomes (D055354)', 'MicroRNAs (D036342)', 'Extracellular Matrix (D005109)'}}",
      "system_message": "You are a CompuCell3D expert. Generate a valid CompuCell3D simulation file.\n    Return ONLY the Python code without any additional text, explanations, or thinking process.\n    The code must include:\n    1. Required imports (CompuCellSetup, steppables)\n    2. A proper simulation class that inherits from steppables.SteppableBasePy\n    3. Required methods (__init__, start, step)\n    4. Basic cell types and parameters based on the ontology annotations",
      "response": "<think>\nOkay, let's tackle this CompuCell3D simulation file based on the provided ontology annotations. First, I need to recall the structure of a typical CompuCell3D Python script. The user wants imports, a simulation class inheriting from SteppableBasePy, and the required methods: __init__, start, and step. Also, the cell types and parameters should align with the given ontology terms.\n\nLooking at the CellOntology, there are endocardial cells and mesenchymal cells. So I'll define these cell types in the start method. The GeneOntology terms include processes like endothelial to mesenchymal transition (EndMT), extracellular matrix (ECM) organization, and hyaluronan biosynthesis. The MeSH terms mention Hyaluronic Acid, Exosomes, MicroRNAs, etc.\n\nI need to set up basic parameters for these processes. Maybe in the start method, I'll assign properties to cells, like secretion rates for hyaluronan. The EndMT could be modeled by a probability of endocardial cells transitioning to mesenchymal. In the step method, each time step could check for this transition based on a condition, maybe a chemical threshold or random chance.\n\nFor ECM organization, perhaps mesenchymal cells secrete more ECM, so I'll set a secretion parameter. Negative regulation of ECM might involve another substance that inhibits it. I can include a 'ecm_inhibitor' field and adjust secretion based on that.\n\nHyaluronic acid biosynthesis (GO:0030212) would involve a secretion field, maybe 'ha_secretion'. Endocardial cells might secrete more of this. Also, exosomes and microRNAs from MeSH could be modeled as fields influencing cell behavior, but since the user asked for basics, maybe just include placeholders.\n\nI should define the chemical fields in the XML, but since the user wants Python code, maybe set them up in the simulation. Wait, CompuCell3D usually uses XML for initial setup, but the Python code can reference them. Alternatively, maybe use the addSecretionField in the steppable.\n\nWait, the code needs to be self-contained. So in the start method, I can create the necessary fields using the CompuCellSetup. The simulation class's __init__ should call the parent __init__.\n\nPutting it all together:\n\nImports: CompuCellSetup and steppables.\n\nThe simulation class inherits from SteppableBasePy, with __init__, start, step.\n\nIn start, register cell types (endocardial and mesenchymal), set up fields like 'ha', 'ecm', 'ecm_inhibitor'. Assign initial secretion rates. Maybe endocardial cells secrete HA, mesenchymal secrete ECM and inhibitor.\n\nIn step, handle EndMT: each step, loop through cells, check if endocardial, and with some probability (maybe based on a condition like HA concentration) change type to mesenchymal. Also, update secretion based on conditions, like if ECM inhibitor is present, reduce ECM secretion.\n\nBut the user might want a basic structure without complex logic. So in step, maybe just a simple probability for transition. For example, each step, endocardial cells have a 0.1% chance to transition.\n\nAlso, set contact energy between cell types to manage adhesion.\n\nTesting parameters: volume, surface terms for cells.\n\nSo, the code outline would be:\n\n- Imports\n- Simulation class with __init__ calling super\n- start method: define cell types, fields, initial cell setup, set cell parameters\n- step method: handle EndMT transitions each step\n\nMake sure to include necessary methods and parameters based on the ontology. For example, glycosaminoglycan metabolism and HA biosynthesis could relate to secretion of a HA field. ECM organization and its negative regulation would involve ECM and inhibitor fields.\n\nInclude basic volume and surface constraints for cells.\n\nI think that's the structure. Now code it with proper syntax.\n</think>\n\n```python\nimport CompuCellSetup\nfrom PySteppables import SteppableBasePy\nimport random\n\nclass SimulationSteppable(SteppableBasePy):\n    def __init__(self, _simulator, _frequency=1):\n        super().__init__(_simulator, _frequency)\n    \n    def start(self):\n        # Define cell types\n        self.endocardial_type = self.cellType(\"ENDOCARDIAL\")\n        self.mesenchymal_type = self.cellType(\"MESENCHYMAL\")\n        \n        # Initialize fields\n        self.createField(\"HA\", \"ConcentrationField\")  # Hyaluronan field\n        self.createField(\"ECM\", \"ConcentrationField\")  # Extracellular Matrix\n        self.createField(\"Inhibitor\", \"ConcentrationField\")  # ECM inhibitor\n        \n        # Set basic cell parameters\n        cell = self.createCell(self.endocardial_type)\n        cell.targetVolume = 25\n        cell.lambdaVolume = 2.0\n        cell.dict[\"ha_secretion\"] = 0.5  # Hyaluronan secretion rate\n    \n    def step(self, mcs):\n        # Endothelial to Mesenchymal Transition (EndMT)\n        for cell in self.cellList:\n            if cell.type == self.endocardial_type:\n                if random.random() < 0.001:  # Stochastic transition probability\n                    cell.type = self.mesenchymal_type\n                    cell.targetVolume = 30\n                    cell.lambdaVolume = 3.0\n                    cell.dict[\"ecm_secretion\"] = 0.3\n                    cell.dict[\"inhibitor_secretion\"] = 0.1\n                \n                # Hyaluronan secretion\n                self.field.HA[cell.xCOM, cell.yCOM, cell.zCOM] += cell.dict.get(\"ha_secretion\", 0)\n            \n            elif cell.type == self.mesenchymal_type:\n                # ECM organization and inhibition\n                self.field.ECM[cell.xCOM, cell.yCOM, cell.zCOM] += cell.dict.get(\"ecm_secretion\", 0)\n                self.field.Inhibitor[cell.xCOM, cell.yCOM, cell.zCOM] += cell.dict.get(\"inhibitor_secretion\", 0)\n\nCompuCellSetup.registerSteppable(SimulationSteppable(CompuCellSetup.getSimulator()))\n```"
    }
  ],
  "outputs": {},
  "metadata": {
    "experiment_model_type": "reasoning",
    "model_type": "reasoning",
    "model_name": "deepseek-ai/deepseek-r1",
    "thinking_process": "<think>\nOkay, let's tackle this CompuCell3D simulation file based on the provided ontology annotations. First, I need to recall the structure of a typical CompuCell3D Python script. The user wants imports, a simulation class inheriting from SteppableBasePy, and the required methods: __init__, start, and step. Also, the cell types and parameters should align with the given ontology terms.\n\nLooking at the CellOntology, there are endocardial cells and mesenchymal cells. So I'll define these cell types in the start method. The GeneOntology terms include processes like endothelial to mesenchymal transition (EndMT), extracellular matrix (ECM) organization, and hyaluronan biosynthesis. The MeSH terms mention Hyaluronic Acid, Exosomes, MicroRNAs, etc.\n\nI need to set up basic parameters for these processes. Maybe in the start method, I'll assign properties to cells, like secretion rates for hyaluronan. The EndMT could be modeled by a probability of endocardial cells transitioning to mesenchymal. In the step method, each time step could check for this transition based on a condition, maybe a chemical threshold or random chance.\n\nFor ECM organization, perhaps mesenchymal cells secrete more ECM, so I'll set a secretion parameter. Negative regulation of ECM might involve another substance that inhibits it. I can include a 'ecm_inhibitor' field and adjust secretion based on that.\n\nHyaluronic acid biosynthesis (GO:0030212) would involve a secretion field, maybe 'ha_secretion'. Endocardial cells might secrete more of this. Also, exosomes and microRNAs from MeSH could be modeled as fields influencing cell behavior, but since the user asked for basics, maybe just include placeholders.\n\nI should define the chemical fields in the XML, but since the user wants Python code, maybe set them up in the simulation. Wait, CompuCell3D usually uses XML for initial setup, but the Python code can reference them. Alternatively, maybe use the addSecretionField in the steppable.\n\nWait, the code needs to be self-contained. So in the start method, I can create the necessary fields using the CompuCellSetup. The simulation class's __init__ should call the parent __init__.\n\nPutting it all together:\n\nImports: CompuCellSetup and steppables.\n\nThe simulation class inherits from SteppableBasePy, with __init__, start, step.\n\nIn start, register cell types (endocardial and mesenchymal), set up fields like 'ha', 'ecm', 'ecm_inhibitor'. Assign initial secretion rates. Maybe endocardial cells secrete HA, mesenchymal secrete ECM and inhibitor.\n\nIn step, handle EndMT: each step, loop through cells, check if endocardial, and with some probability (maybe based on a condition like HA concentration) change type to mesenchymal. Also, update secretion based on conditions, like if ECM inhibitor is present, reduce ECM secretion.\n\nBut the user might want a basic structure without complex logic. So in step, maybe just a simple probability for transition. For example, each step, endocardial cells have a 0.1% chance to transition.\n\nAlso, set contact energy between cell types to manage adhesion.\n\nTesting parameters: volume, surface terms for cells.\n\nSo, the code outline would be:\n\n- Imports\n- Simulation class with __init__ calling super\n- start method: define cell types, fields, initial cell setup, set cell parameters\n- step method: handle EndMT transitions each step\n\nMake sure to include necessary methods and parameters based on the ontology. For example, glycosaminoglycan metabolism and HA biosynthesis could relate to secretion of a HA field. ECM organization and its negative regulation would involve ECM and inhibitor fields.\n\nInclude basic volume and surface constraints for cells.\n\nI think that's the structure. Now code it with proper syntax.\n</think>",
    "cc3d_file_creation": {
      "python_code": "from cc3d.core.PySteppables import *\n\nimport CompuCellSetup\nfrom PySteppables import SteppableBasePy\nimport random\n\nclass SimulationSteppable(SteppableBasePy):\n    def __init__(self, _simulator, _frequency=1):\n        super().__init__(_simulator, _frequency)\n    \n    def start(self):\n        # Define cell types\n        self.endocardial_type = self.cellType(\"ENDOCARDIAL\")\n        self.mesenchymal_type = self.cellType(\"MESENCHYMAL\")\n        \n        # Initialize fields\n        self.createField(\"HA\", \"ConcentrationField\")  # Hyaluronan field\n        self.createField(\"ECM\", \"ConcentrationField\")  # Extracellular Matrix\n        self.createField(\"Inhibitor\", \"ConcentrationField\")  # ECM inhibitor\n        \n        # Set basic cell parameters\n        cell = self.createCell(self.endocardial_type)\n        cell.targetVolume = 25\n        cell.lambdaVolume = 2.0\n        cell.dict[\"ha_secretion\"] = 0.5  # Hyaluronan secretion rate\n    \n    def step(self, mcs):\n        # Endothelial to Mesenchymal Transition (EndMT)\n        for cell in self.cellList:\n            if cell.type == self.endocardial_type:\n                if random.random() < 0.001:  # Stochastic transition probability\n                    cell.type = self.mesenchymal_type\n                    cell.targetVolume = 30\n                    cell.lambdaVolume = 3.0\n                    cell.dict[\"ecm_secretion\"] = 0.3\n                    cell.dict[\"inhibitor_secretion\"] = 0.1\n                \n                # Hyaluronan secretion\n                self.field.HA[cell.xCOM, cell.yCOM, cell.zCOM] += cell.dict.get(\"ha_secretion\", 0)\n            \n            elif cell.type == self.mesenchymal_type:\n                # ECM organization and inhibition\n                self.field.ECM[cell.xCOM, cell.yCOM, cell.zCOM] += cell.dict.get(\"ecm_secretion\", 0)\n                self.field.Inhibitor[cell.xCOM, cell.yCOM, cell.zCOM] += cell.dict.get(\"inhibitor_secretion\", 0)\n\nCompuCellSetup.registerSteppable(SimulationSteppable(CompuCellSetup.getSimulator()))",
      "output_file": "experiments\\batch_reasoning_20250624_020624\\paper_12_Hyaluronan_A_20250624_020624\\run_10\\generated_cc3d_model.cc3d"
    }
  }
}